Doxorubicin reversibly decreases the antithrombogenicity of heparin immobilized on central venous catheters.
This is an in vitro study of the effects of doxorubicin on heparin immobilized on polyvinyl chloride (PVC) tubing. Doxorubicin contains an amino group that binds up to 16 heparin molecules, forming insoluble complexes if they are added to the same infusion. Three systems were tested: doxorubicin in perfusing blood, cerebrospinal fluid, and 0.9% sodium chloride (NaCl). The antithrombogenicity of immobilized heparin is impaired on exposure to doxorubicin. However, the reaction is reversible provided the PVC tubing system is thoroughly washed. Heparinized tubing perfused for 12 hours in blood with doxorubicin (0.027 mg/mL) decreased the activity of the immobilized heparin to 6.0% compared with 43% of that exposed to blood only. Exposure to doxorubicin (0.27 mg/mL) for 15 minutes in NaCl decreased the activity to 3% compared with that of NaCl only. Continuous washing for 10 minutes (8 mL/min) resulted in regained activity. This indicated a reversible reaction between immobilized heparin and doxorubicin. Cyclophosphamide, netilmicin, and gentamicin did not affect the antithrombogenicity of heparin in any solution.
Lundberg
F
F
Department of Medical Microbiology, University Hospital, Lund, Sweden.
Falkenback
D
D
Békássy
A N
AN
Jennerberg
M
M
Riesenfeld
J
J
Ljungh
A
A
D001672:Biocompatible Materials; D002405:Catheterization, Central Venous / Q000295:instrumentation*; D002555:Cerebrospinal Fluid; D003520:Cyclophosphamide; D004317:Doxorubicin; D004912:Erythrocytes / Q000502:physiology*; D005343:Fibrinolytic Agents; D006493:Heparin; D006801:Humans; D008855:Microscopy, Electron, Scanning; D009428:Netilmicin; D010477:Perfusion; D010949:Plasma; D011143:Polyvinyl Chloride
D001672:Biocompatible Materials; D005343:Fibrinolytic Agents; D009428:Netilmicin; D004317:Doxorubicin; D003520:Cyclophosphamide; D011143:Polyvinyl Chloride; D006493:Heparin